Andrew Komjathy serves as Executive at Astria Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Andrew Komjathy has executed 3 insider transactions totaling $670, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 28, 2021 involved gifting 45 shares valued at $0.
Andrew Komjathy currently holds 55 shares of Astria Therapeutics, Inc. (ATXS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Komjathy has been a net buyer of ATXS stock. They have purchased $670 and sold $0 worth of shares.
Andrew Komjathy's most recent insider trade was on Dec 28, 2021, when they sold 45 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 19, 2021 | ATXS | $670 | Purchase | 100 | $6.70 | Discretionary |